LOW LEVEL LASER THERAPY AND PHARMACOTHERAPY FOR MYOFASCIAL PAIN

LOW LEVEL LASER THERAPY VERSUS PHARMACOTHERAPY IN IMPROVING MYOFASCIAL PAIN â??A RANDOMIZED CONTROL CLINICAL TRIAL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052650

Enrollment

Registered

2023-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Sirolase blue diode laser: low level laser therapy for myofascial pain using sirolase blue diode laser Control Intervention1: sirolase blue diode laser, Tablet diclofenac sodium: low le

Eligibility

Inclusion criteria

Inclusion criteria: The study included subjects suffering from myofascial pain with/without limited mouth opening Limited mouth opening is defined as pain-free unassisted mandibular opening of Ë?40 mm

Exclusion criteria

Exclusion criteria: Subjects who received analgesic or antidepressant medicine are excluded from the study Subjects who received treatment for temporomandibular joint disorders associated with rheumatoid arthritis

Design outcomes

Primary

Measure	Time frame
Efficacy of LLLT on myofascial pain will be goodTimepoint: Relief will be measured using vas from 0 to 10 and 4 sessions for each therapy	—

Secondary

Measure	Time frame
Mouth opening will better on laser therapyTimepoint: Relief will be measured using vas from 0 to 10 and 4 sessions for each therapy	—

Countries

India

Contacts

Public ContactDr Gayathri PM

Malabar Dental College and Research Centre Manoor

drdeepakdaryani@gmail.com09980445555

Outcome results